As an NCI designee, part of our charge at Dartmouth Cancer Center is to advance and develop new treatments here in our region and beyond.
Konstantin H. Dragnev, MDWhen someone receives a cancer diagnosis, they’re faced with a slew of fears, concerns, questions and considerations. More often than not, where and how they’ll be treated for their disease is a top priority, and access to clinical trials that may be beneficial to the patient can be a major factor in deciding where to receive treatment. Major urban centers like Boston and New York are well-known medical hubs, but residents of New Hampshire and Vermont need not leave their states for cutting-edge cancer care. As a National Cancer Institute-designated Comprehensive Cancer Center—one of just 53 nationwide, and one of three in New England—Dartmouth Cancer Center offers the exceptional care and resources of an academic medical system and access to clinical trials that offer hope to people facing cancer now, and the potential to help many more people in the future.
In Dartmouth Health’s next “Connect with the CEO” live segment on Monday May 15, at 12 pm, CEO and president Joanne M. Conroy, MD, will be joined by Konstantin H. Dragnev, MD, associate director for clinical research at Dartmouth Cancer Center, for a conversation about clinical trials at Dartmouth Cancer Center. Conroy and Dragnev will discuss clinical trials at Dartmouth Cancer Center, how patients can benefit from clinical trials, and the importance of having a NCI-designated Comprehensive Cancer Center in New Hampshire.
“As an NCI designee, part of our charge at Dartmouth Cancer Center is to advance and develop new treatments here in our region and beyond,” Dragnev said. “We have a robust system in place to support clinical trials not just at the main campus in Lebanon, but at various satellites sites, from down into southern New Hampshire all the way up to St. Johnsbury, VT. People living with cancer and their loved ones face enough hardships as it is; traveling to New York, Boston or another faraway metro area to get the best care shouldn’t have to be part of their struggles. We want everyone in New Hampshire and Vermont to know that, should they get a cancer diagnosis, not only can they get top-notch care and clinical trials close to home, but they can even be part of clinical trials being offered only at Dartmouth Cancer Center at this time. I look forward to my conversation with Dr. Conroy about the work we are doing to save lives and promoting this important information to people around our region.”
To watch the segment live, visit the Dartmouth Health Facebook page at noon. The chat function on the live video will be open and viewers who are logged into Facebook will be able to submit questions via the chat. For those unable to watch live at noon, an archived version will be available later on Facebook and Dartmouth Health's YouTube channel. Questions may be submitted in advance to social@hitchcock.org.
About Dartmouth Cancer Center
Since 1972, Dartmouth Cancer Center (DCC) has combined groundbreaking and advanced cancer research at Dartmouth and the Geisel School of Medicine with award-winning, personalized, compassionate, patient-centered cancer care and clinical trials. At its flagship location at Dartmouth Health’s Dartmouth Hitchcock Medical Center, with 14 locations across New Hampshire and Vermont, DCC is one of fewer than 60 National Cancer Institute-designated Comprehensive Cancer Centers nationally. Each year, DCC manages 74,000 appointments, treats more than 4,500 newly diagnosed patients, and currently offers more than 240 active clinical trials. DCC remains committed to excellence, outreach and education. DCC strives to create new knowledge and impact, accelerate integrated and collaborative research to prevent and cure cancer, enhance survivorship and promote cancer-related health equity. Learn more at cancer.dartmouth.edu.